Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

Why MCK’s failed takeover lost Sharesies a customer
Markets

Why MCK’s failed takeover lost Sharesies a customer

This former Sharesies user made bank on MCK, but is leaving the platform anyway.

Analysts eye upside in property sector as values stabilise
Property

Analysts eye upside in property sector as values stabilise

On average, listed property companies are trading at a 22% discount to NTA.

Inside Ebos’s ‘revolutionary’ $1.1 billion deal
Markets

Inside Ebos’s ‘revolutionary’ $1.1 billion deal

In 2013, Ebos swallowed a giant. Now it’s the end of an era.

Ebos’ index weight grows; NZX 50 drops 0.7%
Markets Market Close

Ebos’ index weight grows; NZX 50 drops 0.7%

The a2 Milk Company sunk about 5%.

Gregor Thompson 03 Jun 2025